Clinical study on the clinical effect of Sophora powder combined with Xianfang-Huoming decoction for ulcerative colitis
Xiaohong Wang
Abstract
Xiaohong Wang
Abstract
Objective To explore the clinical effect of Sophora powder combined with Xianfang-Huoming decoction for ulcerative colitis. Methods A total of 80 UC patients with TCM syndrome of excessive noxious heat were randomly divided into 2 groups (40 patients each group). The Western medicine group(control group) were treated with Mesalazin Enteric-coated tablets, and the Traditional Chinese medicine(observation group) group were treated with Sophora powder combined with Xianfang-Huoming decoction. The tumor necrosis factor-α (TNF-α)and Interleukin-8 (IL-8) were detected. The Mayo index scores were conducted, and the curative effect and the recurrence rate were observed. Results After treatment, the level of TNF-α (66.11 ± 3.72 ng/L vs. 92.61 ± 4.32 ng/L,t=29.398, P<0.01), IL-8 (53.11 ± 2.72 ng/L vs. 69.31 ± 1.32 ng/L,t=33.888, P<0.01)in the observation group were significantly lower than those in the control group. The Mayo index score (2.07 ± 0.57 vs. 3.30 ± 0.93, t=7.132, P<0.01) in the observation group was significantly lower than that in the control group. The total effective rate (92.5% vs. 85.0%, χ2=1.127, P=0.288) in the observation group was not significantly different from that in the control group. The recurrence rate (5.4% vs. 26.5%, χ2=6.005, P=0.013) in the observation group was significantly lower than that in the control group. Conclusions The Sophora powder combined with Xianfang-Huoming decoction can treat the UC patients with TCM syndrome of excessive noxious hest, and the its recurrence rate is low. Key words: Colitis, Ulcerative; Huai Hua San; Xian Fang Huo Ming Yin; Mesalazine
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical effect of Sophora powder combined with Xianfang-Huoming decoction for ulcerative colitis. Methods A total of 80 UC patients with TCM syndrome of excessive noxious heat were randomly divided into 2 groups (40 patients each group). The Western medicine group(control group) were treated with Mesalazin Enteric-coated tablets, and the Traditional Chinese medicine(observation group) group were treated with Sophora powder combined with Xianfang-Huoming decoction. The tumor necrosis factor-α (TNF-α)and Interleukin-8 (IL-8) were detected. The Mayo index scores were conducted, and the curative effect and the recurrence rate were observed. Results After treatment, the level of TNF-α (66.11 ± 3.72 ng/L vs. 92.61 ± 4.32 ng/L,t=29.398, P<0.01), IL-8 (53.11 ± 2.72 ng/L vs. 69.31 ± 1.32 ng/L,t=33.888, P<0.01)in the observation group were significantly lower than those in the control group. The Mayo index score (2.07 ± 0.57 vs. 3.30 ± 0.93, t=7.132, P<0.01) in the observation group was significantly lower than that in the control group. The total effective rate (92.5% vs. 85.0%, χ2=1.127, P=0.288) in the observation group was not significantly different from that in the control group. The recurrence rate (5.4% vs. 26.5%, χ2=6.005, P=0.013) in the observation group was significantly lower than that in the control group. Conclusions The Sophora powder combined with Xianfang-Huoming decoction can treat the UC patients with TCM syndrome of excessive noxious hest, and the its recurrence rate is low. Key words: Colitis, Ulcerative; Huai Hua San; Xian Fang Huo Ming Yin; Mesalazine
Key concepts: Decoction, Medicine, Gastroenterology, Sophora, Internal medicine, Ulcerative colitis, Traditional Chinese medicine, Clinical efficacy